"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

Obstructive sleep apnea during the rapid-eye-movement stage of sleep could be causing damage to parts of the brain that control memory and cognition.

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.

Integrating AI-based delegation tools into breast cancer screening settings could result in significant cost savings for organizations.

Matthew Budoff, MD, detailed new data highlighting CCTA's value when it comes to tracking the progression of coronary atherosclerosis.

Using one of the most powerful MRI scanners to date, researchers believe they have identified subtle neural changes in the brain that precede Parkinson’s disease. 

In a nationwide survey of 3,500 patients, those with higher electronic health literacy, educational attainment or of a younger age were “significantly” likelier to see AI as beneficial.

"This legislation imposes new and costly insurance mandates on private health plans that will ultimately raise insurance premiums for working families and small businesses," said Gov. J. Kevin Stitt.